Table 3.
Association between Patient Characteristics and SUD Outcomes
| SUD Dx (n=92) | p value | Overdose Dx (n=51) | p value | |
|---|---|---|---|---|
| Age | <0.001 | <0.001 | ||
| 14 and Under | 30 (8.0%) | 13 (3.5%) | ||
| 15 and Over | 59 (21.7%) | 35 (12.9%) | ||
| Gender | 0.021 | 0.376 | ||
| Female | 13 (7.5%) | 11 (6.4%) | ||
| Male | 76 (16.0%) | 37 (7.8%) | ||
| Race | <0.001 | <0.001 | ||
| White | 52 (11.0%) | 27 (5.7%) | ||
| Black | 35 (25.0%) | 21 (15.0%) | ||
| Other | 2 (5.9%) | 0 (0.0%) | ||
| Hospital | <0.001 | <0.001 | ||
| Adult | 33 (33.3%) | 18 (18.2%) | ||
| Pediatric | 56 (10.2%) | 30 (5.5%) | ||
| Injury Severity | 0.368 | 0.355 | ||
| Minor/Moderate | 75 (13.8%) | 39 (7.2%) | ||
| Major | 8 (10.1%) | 8 (10.1%) | ||
| Injury Type | <0.001 | <0.001 | ||
| Blunt | 58 (10.7%) | 23 (4.2%) | ||
| Penetrating | 25 (26.3%) | 25 (26.3%) | ||
| Other | 6 (66.7%) | 0 (0.0%) | ||
| Insurance | 0.005 | 0.001 | ||
| Medicaid | 40 (17.2%) | 25 (10.8%) | ||
| Self-Pay | 21 (18.1%) | 10 (8.6%) | ||
| Private | 23 (8.2%) | 9 (3.2%) | ||
| Other | 5 (27.8%) | 4 (22.2%) | ||
| EtOH Positive | 25 (22.9%) | 0.015 | 10 (9.2%) | 0.966 |
| Drug Use | 16 (50.0%) | <0.001 | 3 (9.4%) | 0.106 |
Table 3 shows baseline characteristics of patients who have a future SUD or overdose diagnosis based on ICD-9/10 codes. The percentages reflect the row percentage of patients in each category that had an SUD diagnosis (left column) or overdose diagnosis (right column). For example, 50% of patients that screened positive for drugs during their initial hospital visit had an SUD diagnosis in the 5 years after their discharge.